Opening China Offices Brings FDA Early Test On Bridging Globalization Gaps
This article was originally published in The Tan Sheet
Executive Summary
FDA's opening of offices in China will be an early test of how the agency handles the challenges of globalization, not only in working with foreign governments but also in restructuring itself to operate with worldwide footing
You may also be interested in...
FDA Foreign Inspections To Double In 2010, Led By Human Drugs And Food
FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000
FDA Foreign Inspections To Double In 2010, Led By Human Drugs And Food
FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000
FDA Foreign Inspections To Double In 2010, Led By Human Drugs And Food
FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000